首页> 外文期刊>Leukemia Research Reports >On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
【24h】

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia

机译:三氧化二砷在急性早幼粒细胞白血病的临床治疗中的应用

获取原文
           

摘要

Arsenic is generally considered hypertoxic. However, it has been used in traditional Chinese medicine since ancient times, to treat serious illnesses. Recently, a single dose of arsenic trioxide (As 2 O 3 ) has been found especially effective in treating acute promyelocytic leukemia (APL). Generally speaking, As 2 O 3 is a more effective treatment of APL than other, newer medications and has less severe adverse reactions and greater safety.
机译:砷通常被认为是剧毒的。然而,自远古以来,它已被用于中药治疗严重疾病。最近,已发现单剂量的三氧化二砷(As 2 O 3)对治疗急性早幼粒细胞白血病(APL)特别有效。一般而言,与其他新药相比,As 2 O 3是一种更有效的APL治疗方法,且不良反应较少,安全性更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号